Does pulmonary vasoconstriction play an important role in patients with primary pulmonary hypertension? A skeptic's view of vasodilator therapy

M. Packer

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Despite isolated reports of dramatic hemodynamic and clinical improvement over the past 30 years, most patients with primary pulmonary hypertension fail to benefit from treatment with vasodilator drugs and many develop serious adverse reactions. The failure of this approach strongly suggests that pulmonary vasoconstriction does not play an important role in the pathogenesis of this disorder.

Original languageEnglish (US)
JournalChest
Volume88
Issue number4 SUPPL.
StatePublished - 1985

Fingerprint

Vasoconstriction
Vasodilator Agents
Hemodynamics
Lung
Therapeutics
Familial Primary Pulmonary Hypertension

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Does pulmonary vasoconstriction play an important role in patients with primary pulmonary hypertension? A skeptic's view of vasodilator therapy. / Packer, M.

In: Chest, Vol. 88, No. 4 SUPPL., 1985.

Research output: Contribution to journalArticle

@article{6c40fd8496bd4836ad2f93e03aae8162,
title = "Does pulmonary vasoconstriction play an important role in patients with primary pulmonary hypertension? A skeptic's view of vasodilator therapy",
abstract = "Despite isolated reports of dramatic hemodynamic and clinical improvement over the past 30 years, most patients with primary pulmonary hypertension fail to benefit from treatment with vasodilator drugs and many develop serious adverse reactions. The failure of this approach strongly suggests that pulmonary vasoconstriction does not play an important role in the pathogenesis of this disorder.",
author = "M. Packer",
year = "1985",
language = "English (US)",
volume = "88",
journal = "Chest",
issn = "0012-3692",
publisher = "American College of Chest Physicians",
number = "4 SUPPL.",

}

TY - JOUR

T1 - Does pulmonary vasoconstriction play an important role in patients with primary pulmonary hypertension? A skeptic's view of vasodilator therapy

AU - Packer, M.

PY - 1985

Y1 - 1985

N2 - Despite isolated reports of dramatic hemodynamic and clinical improvement over the past 30 years, most patients with primary pulmonary hypertension fail to benefit from treatment with vasodilator drugs and many develop serious adverse reactions. The failure of this approach strongly suggests that pulmonary vasoconstriction does not play an important role in the pathogenesis of this disorder.

AB - Despite isolated reports of dramatic hemodynamic and clinical improvement over the past 30 years, most patients with primary pulmonary hypertension fail to benefit from treatment with vasodilator drugs and many develop serious adverse reactions. The failure of this approach strongly suggests that pulmonary vasoconstriction does not play an important role in the pathogenesis of this disorder.

UR - http://www.scopus.com/inward/record.url?scp=0022180758&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022180758&partnerID=8YFLogxK

M3 - Article

C2 - 4042735

AN - SCOPUS:0022180758

VL - 88

JO - Chest

JF - Chest

SN - 0012-3692

IS - 4 SUPPL.

ER -